Revenue
$237.3M
▲ 726.7% YoY
Net Income
$16.3M
▲ 124.4% YoY
EPS
$0.07
▲ 121.2% YoY
Cash
$63.8M
▲ 152.9% YoY
FY 2025 · As of 2025-12-31
Last 90 days
| Insider | Type | Date | Shares | Price | Value | |
|---|---|---|---|---|---|---|
Watson W. Mark Director | Buy | May 22, 2026 | 10.0K | $0.65 | $7K | Form 4 ↗ |
Grasman Jeroen Nicolaas Chief Financial Officer | Sell tax | May 19, 2026 | 31.4K | $0.61 | $19K | Form 4 ↗ |
BREITMEYER JAMES B Director | Grant | Apr 23, 2026 | 78.8K | $0.00 | $0 | Form 4 ↗ |
Tucker Sean SVP, Chief Scientific Officer | Sell tax | Mar 28, 2026 | 3.9K | $0.65 | $3K | Form 4 ↗ |
Cummings James F. Chief Medical Officer | Sell tax | Mar 28, 2026 | 3.3K | $0.65 | $2K | Form 4 ↗ |
Berg Edward B SVP, General Counsel | Sell tax | Mar 24, 2026 | 36.4K | $0.69 | $25K | Form 4 ↗ |
Cummings James F. Chief Medical Officer | Sell tax | Mar 24, 2026 | 30.6K | $0.69 | $21K | Form 4 ↗ |
Lo Steven President, Chief Exec Officer | Sell tax | Mar 24, 2026 | 126.0K | $0.69 | $87K | Form 4 ↗ |
Tucker Sean SVP, Chief Scientific Officer | Sell tax | Mar 24, 2026 | 36.4K | $0.69 | $25K | Form 4 ↗ |
Berg Edward B SVP, General Counsel | Sell tax | Mar 18, 2026 | 8.1K | $0.63 | $5K | Form 4 ↗ |
Cummings James F. Chief Medical Officer | Sell tax | Mar 18, 2026 | 6.8K | $0.63 | $4K | Form 4 ↗ |
Lo Steven President, Chief Exec Officer | Sell tax | Mar 18, 2026 | 22.4K | $0.63 | $14K | Form 4 ↗ |